Regulation of T cell homeostasis and memory
T 细胞稳态和记忆的调节
基本信息
- 批准号:8136584
- 负责人:
- 金额:$ 63.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdhesionsAdhesivesAffectApoptosisB-LymphocytesBehaviorBindingCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell Adhesion MoleculesCell DeathCell Surface ProteinsCell physiologyCellsCessation of lifeChimeric ProteinsChronicClinicalCollaborationsDataDevelopmentEffector CellEngineeringEpidemicEventFamilyFundingGenerationsGeneticGoalsGrantHematopoieticHomeostasisImmune systemImmunityIn VitroIndividualInfectionInfluenzaInstructionInterferon Type IIInterferonsInterleukin-17L-SelectinLigandsLigationLinkLungLymphoidMaintenanceMediatingMemoryModelingMusP-selectin ligand proteinPathway interactionsPhenotypePlayPopulationPredispositionPropertyProteinsRegulationReporterRoleSelectinsSignal TransductionT cell regulationT cell responseT memory cellT-LymphocyteT-Lymphocyte SubsetsTimeTransferaseTransgenic OrganismsTuberculosisVascular EndotheliumVirusVirus Diseasescarbohydrate binding proteincell motilitycell typecytokinecytotoxicglycosylationin vivoinfluenzavirusinsightlymph nodesmigrationnovelpandemic influenzareceptor bindingresponsetrait
项目摘要
Understanding mechanisms that regulate memory in T cells is crucial for developing strategies to protect
against epidemic and pandemic influenza viruses. The goal of this project is to determine the contribution of
the selectin family of adhesion molecules (E, P, and L) and the selectin ligand, PSGL-1, to T cell memory
Recently, we found that glycosylated, biologically active ligands for selectins are acquired by a subset of
CD4 and CD8 effectors in the draining lymph nodes after influenza virus infection and represent the majority
of responding T cells in the lungs including IFN-g or IL-17 producers, in vivo correlates of Th1 and Th17
cells, respectively. Moreover, we find that a consistent fraction of memory phenotype T cells express
selectin-binding activity, suggesting that this is a stable heritable trait that distinguishes a subset of memory
cells. In the absence of functional selectin ligands or PSGL-1, CD4 cell expansion and localization in the
lungs after influenza virus infection is unaltered. However, CD4 effectors produce elevated levels of IFN-g
and IL-17 suggesting a role for selectin ligands in dampening the effector response. Importantly, the
development of memory CD4 cells with the capacity for secondary expansion after infection is impaired,
possibly because of altered homeostatic regulation. Our data support the hypothesis that mechanisms
regulated by selectins can be essential for the delivery of signals that control CD4 effector cell responses as
well as the homeostatic maintenance of a subset of memory cells. We will investigate the novel function(s) of
selectins in the regulation of effector and memory T cells in following specific Aims: 1) to determine if
differences in selectin-binding capacity identify memory T cell subsets with distinct functional properties and
homeostatic regulation; 2) to investigate selectin-dependent responses of T cells and the role of selectin-
binding capacity in the generation of memory cells after influenza virus infection; and 3) to identify
mechanisms by which selectins regulate T cell homeostasis. We will take advantage of mice that are
deficient in PSGL-1-/-, mice that lack PSGL-1 signaling, and mice that lack functional selectin ligands due to
deficiency of the IV/VII fucosyl transferases. We will use IFN-g and IL-17 reporter mice, selectin ligand fusion
proteins, and WT and engineered influenza viruses to enable us to assess the responses of polyclonal and
TCR transgenic CD4 cells and make comparisons to CDS cells. In each of these Aims we will collaborate
with Projects 1 and 2 to examine defined subsets of CD4 and CD8 cells in the influenza model. We will
collaborate with project 4, which will determine the relevance of selectins in the tuberculosis model.
RELEVANCE (See instructions):
These studies together with those of projects 1, 2, and 4 will investigate means by which the immune system
controls pulmonary infections and will provide new insights into the regulation of the development and
homeostasis of memory T cells through mechanisms that regulate adhesion and migration that could be
important for strategies to help protect the population from acute as well as chronic infections. Selectin-
binding has the potential to be a new stable marker of memory T cells that have achieved effector function
This would be an important breakthrough that could be extremely valuable in both clinical and basic studies.
了解调节 T 细胞记忆的机制对于制定保护策略至关重要
对抗流行性和大流行性流感病毒。该项目的目标是确定以下人员的贡献
粘附分子选择素家族(E、P 和 L)和选择素配体 PSGL-1 对 T 细胞记忆的影响
最近,我们发现选择素的糖基化、生物活性配体是由一部分获得的
流感病毒感染后引流淋巴结中的 CD4 和 CD8 效应细胞占大多数
肺部应答 T 细胞(包括 IFN-g 或 IL-17 产生者)的数量,Th1 和 Th17 的体内相关性
细胞,分别。此外,我们发现记忆表型 T 细胞的一致比例表达
选择素结合活性,表明这是一种稳定的遗传性状,可以区分记忆的一个子集
细胞。在缺乏功能性选择素配体或 PSGL-1 的情况下,CD4 细胞在
流感病毒感染后,肺部没有变化。然而,CD4 效应子产生的 IFN-g 水平升高
IL-17 表明选择素配体在抑制效应反应中发挥作用。重要的是,
感染后二次扩增能力受损的记忆 CD4 细胞的发育,
可能是由于体内平衡调节的改变。我们的数据支持以下假设:机制
受选择素调节对于控制 CD4 效应细胞反应的信号传递至关重要
以及记忆细胞子集的稳态维持。我们将研究的新颖功能
选择素在效应 T 细胞和记忆 T 细胞的调节中的作用如下: 1) 确定是否
选择素结合能力的差异识别出具有不同功能特性的记忆T细胞亚群
体内平衡调节; 2)研究T细胞的选择素依赖性反应以及选择素的作用
流感病毒感染后记忆细胞生成的结合能力; 3) 识别
选择素调节 T 细胞稳态的机制。我们将利用老鼠
PSGL-1-/- 缺陷的小鼠、缺乏 PSGL-1 信号传导的小鼠以及由于以下原因而缺乏功能性选择素配体的小鼠
IV/VII 岩藻糖基转移酶缺乏。我们将使用 IFN-g 和 IL-17 报告小鼠,选择素配体融合
蛋白质、WT 和工程化流感病毒,使我们能够评估多克隆和
TCR 转基因 CD4 细胞并与 CDS 细胞进行比较。我们将在每一个目标中进行合作
与项目 1 和 2 一起检查流感模型中定义的 CD4 和 CD8 细胞亚群。我们将
与项目 4 合作,该项目将确定选择素在结核病模型中的相关性。
相关性(参见说明):
这些研究与项目 1、2 和 4 的研究一起将研究免疫系统
控制肺部感染,并将为疾病的发展和调节提供新的见解。
通过调节粘附和迁移的机制来实现记忆 T 细胞的稳态
对于帮助保护人们免受急性和慢性感染的战略非常重要。选择-
结合有可能成为已实现效应功能的记忆 T 细胞的新稳定标记
这将是一个重要的突破,在临床和基础研究中都极具价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda Mac Pherson Bradley其他文献
Linda Mac Pherson Bradley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda Mac Pherson Bradley', 18)}}的其他基金
Targeting Checkpoint Inhibition in Anti-Tumor Responses
抗肿瘤反应中针对检查点抑制
- 批准号:
10202111 - 财政年份:2021
- 资助金额:
$ 63.07万 - 项目类别:
Targeting Checkpoint Inhibition in Anti-Tumor Responses
抗肿瘤反应中针对检查点抑制
- 批准号:
10372199 - 财政年份:2021
- 资助金额:
$ 63.07万 - 项目类别:
Regulation of CD4+ T cell responses during chronic viral infection
慢性病毒感染期间 CD4 T 细胞反应的调节
- 批准号:
10197841 - 财政年份:2020
- 资助金额:
$ 63.07万 - 项目类别:
Regulation of CD4+ T Cell Responses During Chronic Viral Infection
慢性病毒感染期间 CD4 T 细胞反应的调节
- 批准号:
10322954 - 财政年份:2020
- 资助金额:
$ 63.07万 - 项目类别:
Frontiers in Fundamental and Translational Immunology
基础和转化免疫学前沿
- 批准号:
10318101 - 财政年份:2018
- 资助金额:
$ 63.07万 - 项目类别:
Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
- 批准号:
9302010 - 财政年份:2017
- 资助金额:
$ 63.07万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 63.07万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 63.07万 - 项目类别:
Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
- 批准号:
9445426 - 财政年份:2017
- 资助金额:
$ 63.07万 - 项目类别:
Linking the microbiome and immune-checkpoint in melanoma by RNF5
RNF5 连接黑色素瘤中的微生物组和免疫检查点
- 批准号:
10098006 - 财政年份:2017
- 资助金额:
$ 63.07万 - 项目类别:
相似国自然基金
基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
- 批准号:82305302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组胺通过调控Th1/Th2平衡促进宫腔粘连的机制研究
- 批准号:82360298
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
宫腔粘连子宫内膜NK细胞异常破坏间质稳态致内膜纤维化的机制研究
- 批准号:82371641
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
用于连续监测心力衰竭生物标志物的无试剂传感器技术
- 批准号:
10636089 - 财政年份:2023
- 资助金额:
$ 63.07万 - 项目类别:
Novel strategies to accelerate repair of drug-induced hepatotoxicity
加速修复药物引起的肝毒性的新策略
- 批准号:
10718314 - 财政年份:2023
- 资助金额:
$ 63.07万 - 项目类别:
Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
- 批准号:
10584768 - 财政年份:2023
- 资助金额:
$ 63.07万 - 项目类别:
Biomolecule releasing adhesive for cell-mediated labral repair
用于细胞介导的盂唇修复的生物分子释放粘合剂
- 批准号:
10736334 - 财政年份:2023
- 资助金额:
$ 63.07万 - 项目类别:
Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
- 批准号:
10712721 - 财政年份:2023
- 资助金额:
$ 63.07万 - 项目类别: